Literature DB >> 19787522

Attention and working memory deficits in mild cognitive impairment.

Nichole L J Saunders1, Mathew J Summers.   

Abstract

Mild cognitive impairment (MCI) has emerged as a classification for a prodromal phase of cognitive decline preceding the emergence of Alzheimer's disease (AD). We examined neuropsychological functioning in a sample of 60 adults with amnestic-MCI (a-MCI), 32 with subjective complaints of memory impairment (subjective-MCI, s-MCI), 14 with mild AD, and 25 age-matched controls. Both the a-MCI and s-MCI groups displayed impaired attentional processing, working memory capacity, and semantic language, with a-MCI displaying additional impairments to verbal and/or visual memory. These results indicate that further research is needed to examine cognitive decline in nonamnestic variants of MCI.

Entities:  

Mesh:

Year:  2009        PMID: 19787522     DOI: 10.1080/13803390903042379

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  42 in total

1.  Impaired retention is responsible for temporal order memory deficits in mild cognitive impairment.

Authors:  M Meredith Gillis; Kristen M Quinn; Pamela A T Phillips; Benjamin M Hampstead
Journal:  Acta Psychol (Amst)       Date:  2013-03-27

2.  Delay and probability discounting as candidate markers for dementia: an initial investigation.

Authors:  Cutter A Lindbergh; Antonio N Puente; Joshua C Gray; James Mackillop; L Stephen Miller
Journal:  Arch Clin Neuropsychol       Date:  2014-09-18       Impact factor: 2.813

3.  Less wiring, more firing: low-performing older adults compensate for impaired white matter with greater neural activity.

Authors:  Sander M Daselaar; Vijeth Iyengar; Simon W Davis; Karl Eklund; Scott M Hayes; Roberto E Cabeza
Journal:  Cereb Cortex       Date:  2013-10-23       Impact factor: 5.357

4.  Repeated retrieval during working memory is sensitive to amnestic mild cognitive impairment.

Authors:  Lucas S Broster; Juan Li; Charles D Smith; Gregory A Jicha; Frederick A Schmitt; Yang Jiang
Journal:  J Clin Exp Neuropsychol       Date:  2013-09-30       Impact factor: 2.475

Review 5.  Sleep disturbances in Alzheimer's and Parkinson's diseases.

Authors:  Sarah M Rothman; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2012-05-03       Impact factor: 3.843

6.  A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging.

Authors:  Kathleen M Hayden; Jill M McEvoy; Colton Linnertz; Deborah Attix; Maragatha Kuchibhatla; Ann M Saunders; Michael W Lutz; Kathleen A Welsh-Bohmer; Allen D Roses; Ornit Chiba-Falek
Journal:  Alzheimers Dement       Date:  2012-08-03       Impact factor: 21.566

7.  Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.

Authors:  Laura D Baker; Suzanne M Barsness; Soo Borson; George R Merriam; Seth D Friedman; Suzanne Craft; Michael V Vitiello
Journal:  Arch Neurol       Date:  2012-11

8.  Alterations in structural rich-club connectivity of the precuneus are associated with depressive symptoms among individuals with subjective memory complaints.

Authors:  Geon Ha Kim; Jung Yoon Kim; Jieun E Kim; Jiyoung Ma; Bori R Kim; Jooyeon Jamie Im; Hyeonseok S Jeong; Eun Namgung; Suji Lee; Ilhyang Kang; In Kyoon Lyoo; Jaeuk Hwang; Sujung Yoon
Journal:  Cogn Affect Behav Neurosci       Date:  2019-02       Impact factor: 3.282

9.  Bacopa monnieri ameliorates memory deficits in olfactory bulbectomized mice: possible involvement of glutamatergic and cholinergic systems.

Authors:  Xoan Thi Le; Hang Thi Nguyet Pham; Phuong Thi Do; Hironori Fujiwara; Ken Tanaka; Feng Li; Tai Van Nguyen; Khoi Minh Nguyen; Kinzo Matsumoto
Journal:  Neurochem Res       Date:  2013-08-15       Impact factor: 3.996

10.  Examination of Variables That May Affect the Relationship Between Cognition and Functional Status in Individuals with Mild Cognitive Impairment: A Meta-Analysis.

Authors:  Courtney Mcalister; Maureen Schmitter-Edgecombe; Richard Lamb
Journal:  Arch Clin Neuropsychol       Date:  2016-01-06       Impact factor: 2.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.